We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current EVGN market cap is 9.5M. The company's latest EPS is USD -4.7015 and P/E is -0.40.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 641k | 654k | 3.77M | 4.19M | 914k |
| Operating Income | -6.8M | -7.9M | -4.18M | -4.09M | -6.12M |
| Net Income | -6.27M | -7.02M | -3.98M | -3.86M | -5.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 753k | 1.04M | 930k | 5.18M | 5.64M |
| Operating Income | -21.17M | -24.81M | -30.95M | -26.94M | -26.51M |
| Net Income | -18.11M | -23.37M | -27.79M | -26.64M | -23.88M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 49.48M | 53.34M | 57.75M | 46.78M | 40.97M |
| Total Liabilities | 20.98M | 22.23M | 21.88M | 21.4M | 21.03M |
| Total Equity | 28.5M | 31.11M | 35.86M | 25.38M | 19.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 71.36M | 71.92M | 76.3M | 56.13M | 51.1M |
| Total Liabilities | 11.15M | 15.03M | 12.88M | 21.34M | 22.42M |
| Total Equity | 60.22M | 56.88M | 63.42M | 34.79M | 28.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.24M | -5.09M | -4.32M | -4.11M | -9.57M |
| Investing | 304k | -7.9M | 3.64M | -4.36M | -1.15M |
| Financing | 53k | 10.45M | 7.8M | -367k | -518k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.67M | -19.51M | -24.72M | -23.68M | -21.58M |
| Investing | 37.14M | 9.42M | -20.57M | 13.27M | -4.54M |
| Financing | 9.31M | 20.37M | 30.28M | 9.34M | 18.15M |
| Market Cap | 9.5M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 1.68 |
| Price to Cash Ratio | 0.46 |
| Price to Book Ratio | 0.33 |
| Dividend Yield | - |
| Shares Outstanding | 5.08M |
| Average Volume (1 week) | 132.21k |
| Average Volume (1 Month) | 76.01k |
| 52 Week Change | -78.75% |
| 52 Week High | 10.40 |
| 52 Week Low | 1.20 |
| Spread (Intraday) | 0.02 (1.06%) |
| Company Name | Evogene Ltd |
| Address |
13 gad feinstein street, park rehovot rehovot, center 7414002 |
| Website | https://www.evogene.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
